Related Experiment Videos
Approaches to the artificial heart. Invited speaker
Surgery
|August 1, 1981
Summary
The implantable artificial heart has advanced significantly, now supporting circulation for over 5 months. Future electrically powered artificial hearts aim for permanent replacement in end-stage heart disease patients.
Area of Science:
- Biomedical Engineering
- Cardiovascular Devices
- Artificial Organs
Background:
- The implantable artificial heart has progressed over 20 years, moving from concept to devices supporting circulation for over 5 months.
- Early challenges included thromboembolism and device breakage; current limitations in animal models are infection, valve obstruction, and calcification.
- Air-powered artificial hearts have limited clinical use due to bulky components and infection risk, primarily for heart transplant candidates.
Purpose of the Study:
- To review the evolution and current status of implantable artificial hearts.
- To discuss the development of permanently implantable, electrically driven artificial hearts.
- To highlight the potential for
- off-the-shelf
- devices for end-stage heart disease.
Main Methods:
- Review of historical development and current research in artificial heart technology.
- Focus on advancements in energy conversion and power sources, moving from nuclear to electrical systems.
- Bench testing and preparation for long-term animal studies of electrically driven devices.
Main Results:
- Artificial hearts can now support circulation for extended periods (over 5 months in animal studies).
- Electrically driven artificial hearts utilizing samarium-cobalt magnet brushless direct-current motors are under development.
- Nuclear-powered systems have been largely abandoned due to cost and safety concerns.
Conclusions:
- Significant progress has been made in artificial heart technology, addressing previous limitations.
- Electrically powered artificial hearts represent the future for permanent cardiac replacement.
- The goal is to provide readily available artificial hearts for patients with severe, non-repairable heart conditions.